Product Description
-BEEDAN is a targeted therapy used to treat certain cases of chronic myelogenous leukemia and acute lymphoblastic leukemia .
-Dasatinib is an ATP-competitive protein tyrosine kinase inhibitor. The main targets of dasatinib are BCR/Abl.